21 June 2020

25 June, 15:00

We are starting to be able to analyze the challenges that the healthcare system is facing as a result of the coronavirus pandemic and the lessons that can be drawn from this.
Having a stable functioning healthcare system is more important than ever in a crisis. For many types of patient, receiving the treatment required in a timely manner and getting hold of medication is critically important. Patients with cancer, cardiovascular diseases and endocrine disorders are among those in need of special consideration, given that they are at risk of getting seriously ill from coronavirus.
During the pandemic, swift and well-informed decisions have been taken to coordinate the circulation of medication at all levels – decisions which must be considered and taken in future. The enforced changes to how medical care can be administered has brought the need to take decisions on the provision of medical care via paramedical, hospital and home-based services, as well as via the high-quality reformed OMS system, into sharp focus. 
What changes must be incorporated in the National Healthcare Project to build an effective medical treatment system following the pandemic? How do we ensure that people can easily get hold of the medicines they need? Why is it important to ensure the continuity of medical care plans across hospitals and paramedical services? What opportunities are there to roll out essential medicines more expeditiously? Can we guarantee that imported medication will be transferred securely within the required time period? What should the state support package be so as to prevent a lack of medicine on the Russian market in the event of a pandemic?

Informational Partners:

ip1.jpg  ip3.jpg

Title Partner

AstraZeneca Pharmaceuticals LLC

General director of AstraZeneca in Russia and Eurasia

Irina Panarina
Генеральный директор «АстраЗенека», Россия и Евразия

Since may, 2017 Irina has been holding the position of general director of AstraZeneca in Russia and Eurasia. 

 Irina is responsible for the company business at the level of Russia and Eurasia region. She is also in charge of AstraZeneca Russia. 

Irina Panarina has been working in AstraZeneca since 2009. In October, 2015 Irina joined Russian team as Director of Cardiology and Diabetes business unit.

Before joining AstraZeneca Russia Irina Panarina held the position of general director of AstraZeneca Ukraine. 

Prior to joining AstraZeneca, Irina held regional positions in the GSK Pharma's headquarter in London, the UK. 

Irina Panarina has a vast experience in marketing, product portfolio management and team development. 

Irina Panarina has graduated from Newcastle University and London South Bank University. She has also completed an MBA in INSEAD Business School. 

Since February 2018, Irina Panarina has been a member of the General Council of the All Russia Public Organization Business Russia. In March 2018, she was appointed as Business Russia Ambassador to Sweden. In December 2019, Irina Panarina joined the Coordinating Council of Business Russia.


Natalia Kolerova

Country President of Novartis Group Russia 
General Manager of the Novartis Oncology in Russia, Ukraine and CIS countries

Natalia Kolerova was appointed Country President of Novartis Group Russia in September 2019. Since 2014 Natalia has been the General Manager of the Oncology business division of the company and continues to execute these responsibilities following her appointment. 

Natalia joined Novartis in 2008 as the Head of the Specialties Business unit. Subsequently, Natalia served as the Head of the Market Access function and was responsible for ensuring the availability of drugs in the oncological portfolio of the company at the federal and regional levels.

Prior to joining Novartis, Natalia held senior positions in the Russian offices of the international pharmaceutical companies Abbott Lababorats (Abbott Lab SA) and Sanofi-Aventis (Sanofi-Aventis).

Natalia graduated from the I.M. Sechenov First Moscow State Medical University majoring in Pharmacy, as well as Lomonosov Moscow State University, majoring in Sociology. Natalia also holds a MBA degree.

Back to news